The global nasal corticosteroids market is entering a sustained growth phase as respiratory and nasal disorders become increasingly common worldwide. Valued at US$ 6.6 Bn in 2023, the market is expected to grow at a 5.2% CAGR between 2024 and 2034, reaching approximately US$ 11.4 Bn by the end of 2034.👉 Get sample market research report copy...